The DOI matches its Crossref record.
Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation.
Open accessAbstract
Ablation of greater than 70% of renal mass in the rat results in hypertension, proteinuria, and glomerular sclerosis of the remnant kidney. Rats with a remnant kidney have increased excretion of thromboxane in the urine when compared with normal rats. Chronic oral administration of OKY 1581, an inhibitor of thromboxane synthesis, in rats with a remnant kidney increases renal blood flow and glomerular filtration rate (GFR), decreases protein and thromboxane excretion in the urine, lowers blood pressure and cardiac index, and improves renal histology. The degree of hypertrophy of the remnant kidney was unaffected by administration of OKY 1581. Calculated values for single nephron plasma flow and GFR were significantly greater in rats with remnant kidneys given OKY 1581 than in rats given saline. Acute i.v. administration of OKY 1581 increased renal plasma flow and GFR in rats with a remnant kidney but not in normal rats or rats with a remnant kidney previously treated with acetylsalicyclic acid. OKY 1581 markedly inhibited platelet aggregation. We suggest that in this model of renal disease platelet aggregation and intraglomerular thrombosis play a key role in the development of glomerulosclerosis. Inhibition of platelet aggregation prevents development of glomerulosclerosis, hypertension, and cardiac hypertrophy. We suggest that hyperperfusion and hyperfiltration per se occurring in remnant glomeruli are not directly responsible for the development of glomerulosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Progression of Renal Disease
Epstein, F. H., Klahr, S., Schreiner, G., & Ichikawa, I. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806233182505 · Cited by 828
Self-citationNephron adaptation to renal injury or ablation
Brenner, B. M. (1985) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1985.249.3.f324 · Cited by 641
Clinical Implications of Prostaglandin and Thromboxane A2Formation
Oates, J. A., FitzGerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., & Roberts, L. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809223191206 · Cited by 444
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats
Kasiske, B. L., O'donnell, M. P., Cleary, M. P., & Keane, W. F. (1988) · Kidney International · doi:10.1038/ki.1988.51 · Cited by 409
Floege, J., Burns, M. W., Alpers, C. E., Yoshimura, A., Pritzl, P., Gordon, K., Seifert, R. A., Bowen-Pope, D. F., Couser, W. G., & Johnson, R. J. (1992) · Kidney International · doi:10.1038/ki.1992.42 · Cited by 404
Metadata
- Authors
- Purkerson, M. L., Joist, J. H., Yates, J., Valdes, A., Morrison, A., & Klahr, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1985-01
- Volume
- 82
- Issue
- 1
- Pages
- 193-197
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1992286264
- Cited by
- 189
- References
- 0
- FWCI
- 22.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. https://app.cochat.ai/papers/10.1073/pnas.82.1.193
- The paper
- Purkerson, M. L., Joist, J. H., Yates, J., Valdes, A., Morrison, A., & Klahr, S. (1985). Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.82.1.193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.